Roche’s test, which measures the blood level of pTau181, a protein that builds up in the brain tissue of Alzheimer’s patients ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...

The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

The test—developed in collaboration with Eli Lilly and Co.—does not diagnose Alzheimer’s but is designed to rule out the ...

A new study has identified a simple blood test used to measure insulin resistance that may also help doctors determine which people with early stage Alzheimer’s disease are most likely to experience ...

Discover how to rejuvenate your brain with simple "neurogymnastics," cutting-edge therapies, and expert advice on diet, ...

Increasing social media usage among children has been linked to a decline in cognitive performance. A JAMA study involving ...

Research has shown that adolescents' use of social media (SNS) is closely related to cognitive decline. The University of ...

Quitting smoking during midlife or even later on can help slow down age-related cognitive decline, a new study suggests ...